German Version French Version

Paroxetine (3S,4R)-4-(4-Fluorphenyl)-3-{[3,4-methylendioxy)phenoxy]methyl}piperidin, C19H20FNO3, MW 329,37 g/mol

Selective Serotonin Reuptake Inhibitor (SSRI)

Trade Mark: Paxil®, Seroxat®, Tagonis®



Treatment of depressive illnes, obsessive-compulsive disorder, panic disorder, social phobia, post-traumatic stress disorder, generalised anxiety disorder. Contraindicated for patients under 18 years of age (high suicide risk)


Do not use with MAO inhibitors, because of the danger of a Serotonine syndrome.

Adverse Effects

Especially at the beginning, nausea can occur. When setting off, reduce dose slowly, increased risk of suicides.


The determination of Paroxetine can take place after extraction by means of HPLC/DAD. Therapeutic levels: 0.01-0.05 µg/ml.

Overview SSRI

Overview Antidepressiva

Custom Search




Last modification (M-D-Y): 02/08/2019 - IMPRINT - FAQ